Tools bought without a workflow
A scribe in one department, a chatbot in another, a lead-scoring add-on from a conference. Together they create new logins, new data flows and nobody who owns the result.
We rank use cases by value, risk and readiness, then name an owner and a success measure for each one before anything is bought.
AI strategy is the set of decisions about which workflows to apply AI to, in what order, with which data, under whose ownership and against which business result. For a healthcare business it also sets the boundaries: what stays with qualified professionals, what data tools may touch, and what you will not automate at all.
A scribe in one department, a chatbot in another, a lead-scoring add-on from a conference. Together they create new logins, new data flows and nobody who owns the result.
A pilot with no success measure agreed in advance cannot succeed or fail, so it simply continues. Leadership cannot decide whether to scale it.
The medical director wants documentation help, the billing manager wants denial support, marketing wants content drafts. Without a scoring method, the loudest request or the most persuasive vendor wins.
The NHS evaluation of ambient tools warns that minutes saved do not automatically turn into extra appointments or cash savings. AI work needs a commercial target, not just an efficiency story.
We start with what must change this year, such as referral volume, days in accounts receivable or sales cycle length, then walk the workflows that drive it with the people who do the work.
Each gets a value score, a risk score (what happens when the tool is wrong, and to whom) and a readiness score covering data, integrations and staff time.
We compare configuring something you own, buying a specialist product and building a custom workflow, and assess vendors against your workflow and exit options rather than their demo.
Each pilot has a named owner, baseline, success measure, stop rule and review date before it starts. A pilot that misses its measure is a useful result.
Early wins build trust and shared foundations, while communication, training and role changes are planned alongside the technology.
Strategy is a leadership discipline, and AI is an analysis aid inside it. Executives and clinical leads set the boundaries; the tools help us gather and compare evidence faster.
One list of every AI idea and tool already in use, scored on value, risk and readiness with criteria leadership agrees.
A side-by-side view of the three paths, including effort, data needs, ownership and the cost of leaving.
A checklist for workflow fit, data handling and support. Where a product must talk to your systems, we scope the data and integrations work up front.
Baselines, success measures and stop rules written before launch, using numbers you already track.
A phased plan ordered by dependency and trust, with named owners and a review rhythm leaders can keep.
Who owns each use case, who is trained, which roles change and how staff concerns are heard.
Illustrations of how this work looks in practice. They describe workflows, not client results.
A group receiving separate AI requests from every site scores them together, picks those that share infrastructure and defers the rest with a written reason.
MSOs & GroupsA billing company tests coding support tools against its own sample of denied claims and decides which part to buy and which to configure.
Medical Billing & RCMA service line leader picks one patient access workflow that sits next to the EHR vendor's tools, and writes the measure before the pilot starts.
Hospitals & SystemsA practice manager learns staff paste referral details into a public tool. The strategy sets approved tools, a rule on protected health information and a route for requesting new ones.
Medical ClinicsAI work matters commercially only if it changes a number the business already tracks. We tie each use case to attract, convert, retain or grow, and connect the roadmap to your go-to-market plan so the same priorities drive both.
Interviews with leaders and frontline staff, a review of current tools and spend, and a baseline for the numbers you want to move.
A scored inventory, a build, buy or configure view for each item, and a shortlist leaders can approve in one meeting.
We support the first pilots with whichever path scored best, whether a configured tool, AI agents for patient access or a workflow automation.
Read results against the measures, scale, change or stop each pilot, and leave your team the scoring method and review rhythm.
The aim is a shorter list of active initiatives, each with an owner and a measure.
Duplicate subscriptions and tools nobody owns are flagged for retirement or consolidation.
Procurement runs against a written checklist and your own workflow.
Leaders can say scale, change or stop, and point to the baseline and result behind it.
What improves depends on your starting point, data quality, how well your systems connect and whether people adopt the change. A strategy cannot create capacity your workflows do not release, and we do not promise a particular return. Survey figures are not a forecast for your business, so each pilot is judged against your own baseline.
A tool answers one task. A strategy decides which tasks matter, in what order and who owns the result. Without one, each department buys its own product and the business inherits overlapping logins and nobody accountable.
Yes, and it is often more useful then. An existing tool shows what adoption really looks like in your team. We decide whether to keep, consolidate or replace it, and connect it to AI governance so it has a policy and an owner.
We score each path on workflow fit, data access, security terms, effort and the cost of leaving. Configuring something you own is often the lowest-risk start. Buying suits mature, bounded tasks, and a custom build is reserved for workflows specific to your business.
Only as far as the research allows. A McKinsey survey of 150 US healthcare leaders reported 50% implementing gen-AI and 19% implementing agentic AI, with 51% pursuing agentic proofs of concept. That is a small sample from late 2025, so we judge your options against your own workflows.
We recommend criteria and a shortlist for your situation. We do not sell AI tools, so the assessment is about fit rather than quota. If configuring what you already own is enough, we will say so.
Then the roadmap says so plainly. Data quality, patient matching and system access are scored as readiness, and use cases that depend on missing data move later or begin with the data and integrations work they depend on. Staff time for training is scored the same way.
Book a discovery call and bring your current tools, your biggest operational frustrations and the numbers you want to move. We will tell you what is worth doing first and what is not.